Cachet Pharmaceutical Co., Ltd.

XSEC:002462 Stock Report

Market Cap: CN¥3.7b

Cachet Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Yibin Huang

Chief executive officer

CN¥1.2m

Total compensation

CEO salary percentagen/a
CEO tenure3.5yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure3yrs

Recent management updates

Recent updates

CEO

Yibin Huang (53 yo)

3.5yrs

Tenure

CN¥1,231,100

Compensation

Mr. Yibin Huang has been the President at Cachet Pharmaceutical Co., Ltd. since August 12, 2021 and served as its President Assistant and serves as its Director since December 14, 2022. Mr. Huang has been...

Board Members

NamePositionTenureCompensationOwnership
Yibin Huang
President & Non-Independent Director2.2yrsCN¥1.23mno data
Jun Lin
VP & Non-Independent Director2.2yrsCN¥887.40kno data
Xiong Yan
Independent Director3.9yrsCN¥142.90kno data
Wen Li Xu
Chairman of the Board of Directorsno dataCN¥1.60mno data
Weidong Cai
Non-Independent Director7yrsno datano data
Lijun Zhang
Member of the Supervisory Board7yrsno datano data
Liang Yu
Independent Director3.9yrsCN¥142.90kno data
Ke Xu
Supervisor5.1yrsno datano data
Wei Gao
Employee Supervisorno datano datano data
Haiyan Zhang
Independent Director2.2yrsCN¥142.90kno data
Wei Pan
Non-Independent Director2.2yrsno datano data
Xiaoxia Shang
Supervisor2.2yrsno datano data

3.0yrs

Average Tenure

54yo

Average Age

Experienced Board: 002462's board of directors are considered experienced (3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 03:39
End of Day Share Price 2025/01/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cachet Pharmaceutical Co., Ltd. is covered by 17 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhouyu DengBOCI Research Ltd.
Weiya ZhangBOCI Research Ltd.
Wei Xuan HuangChangjiang Securities Co. LTD.